News

BridgeBio Pharma, Inc.: BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
BridgeBio Pharma, Inc. (Nasdaq: BBIO) ("BridgeBio" or the "Company"), a commercial-stage biopharmaceutical company focused on genetic diseases, today ...
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on ...
Biotech stocks to own amid market volatility – Piper Sandler
The sector is defensive, and biopharmaceuticals have, for the most part, limited tariff and transfer price exposure, he ...
BridgeBio management to meet with Piper Sandler
Meeting to be held in Boston on April 8 and in New York on April 9 hosted by Piper Sandler.Stay Ahead of the Market: Discover outperforming ...
Why these 38 stocks getting trashed in the tariff crash are primed to outperform the S&P 500 over the next year: Evercore
Evercore ISI sees cheap buying opportunities in various stock market sectors as the trade war sends stocks into a bear market ...